BioAtla to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
Share this article Share this article SAN DIEGO, Jan. 8, 2021 /PRNewswire/ -- BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that Jay M. Short, Ph.D., Chief Executive Officer, and Scott Smith, President, with participation by other BioAtla executives, will present at the 39 th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021, at 2:50 PM Eastern Time. About BioAtla, Inc. BioAtla is a global clinical-stage biotechnology company with operations in...
Source: prnewswire.com